ArriVent BioPharma (AVBP) director receives grant of 13,562 stock options at $31.74
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ArriVent BioPharma, Inc. director John Hohneker received a grant of non-qualified stock options covering 13,562 shares of common stock. The options have an exercise price of $31.74 per share, expire on June 17, 2036, and vest on the first anniversary of the June 18, 2026 grant date, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hohneker John
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 13,562 | $0.00 | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 13,562 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 13,562 options
Exercise price: $31.74 per share
Underlying shares: 13,562 shares
+2 more
5 metrics
Option grant size
13,562 options
Non-qualified stock option grant on June 18, 2026
Exercise price
$31.74 per share
Strike price for the non-qualified stock option
Underlying shares
13,562 shares
Common stock covered by the option grant
Expiration date
June 17, 2036
Option expiration for the granted award
Shares following transaction
13,562 options
Total derivative securities held after the grant
Key Terms
Non-Qualified Stock Option, exercise price, expiration date, underlying security, +1 more
5 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
exercise price financial
"conversion_or_exercise_price: "31.7400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
vesting financial
"The shares underlying this option vest on the first anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did ArriVent BioPharma (AVBP) director John Hohneker report on this Form 4?
He reported receiving a grant of non-qualified stock options for 13,562 shares of common stock. These options are a form of equity compensation, giving him the right to buy shares at a fixed exercise price in the future if they vest.
How many ArriVent BioPharma (AVBP) options were granted to John Hohneker?
He was granted options on 13,562 shares of ArriVent BioPharma common stock. The filing shows this entire amount as held following the transaction, reflecting a new equity award rather than a purchase or sale in the open market.
What is the exercise price of John Hohneker’s ArriVent BioPharma (AVBP) options?
The options have an exercise price of $31.74 per share. This means he can choose to buy ArriVent BioPharma common stock at $31.74 for each optioned share once vested and before the options expire.
When do John Hohneker’s ArriVent BioPharma (AVBP) options vest?
The shares underlying this option vest on the first anniversary of the June 18, 2026 grant date. Vesting is conditioned on his continued service with the company through that vesting date, according to the footnote disclosure.
When do John Hohneker’s ArriVent BioPharma (AVBP) options expire?
These non-qualified stock options expire on June 17, 2036. If they are not exercised by that expiration date, they will lapse and no longer provide the right to buy ArriVent BioPharma common stock at the stated exercise price.